Pain Processing in Anxiety and Depression

Verified by: Danish Pain Research Center, August 2009
First Received: November 16, 2007 | Last Updated: October 7, 2009 | Phase: N/A | Start Date: November 2007
Overall Status: Completed | Estimated Enrollment: 71
  • …
  • Tell a FriendPrint

The purpose of the study is to investigate pain, anxiety and depression in patients with panic anxiety disorders without pain or depression without pain compared with healthy...

Brief Summary

Official Title: “Pain, Anxiety and Depression in Patients With Panic Anxiety Disorders Without Pain or Depression Without Pain Compared With Healthy Volunteers”

The purpose of the study is to investigate pain, anxiety and depression in patients with panic anxiety disorders without pain or depression without pain compared with healthy volunteers

  • Study Type: Observational
  • Study Design: Observational Model: Case Control, Time Perspective: Prospective

Intervention(s) in this Clinical Trial

  • Other: Observation
    • N.A.

Arms, Groups and Cohorts in this Clinical Trial

  • : 1
    • Patients with panic anxiety disorder without pain
  • : 2
    • Patients with depression without pain
  • : 3
    • Healthy controls

Outcome Measures for this Clinical Trial

Primary Measures

  • Quantitative sensory testing
    • Time Frame: 3-4 hours
      Safety Issue?: No

Secondary Measures

  • Symptom checklist 92
    • Time Frame: 3-4 hours
      Safety Issue?: No
  • Hamilton Depression and Anxiety Rating Scale
    • Time Frame: 3-4 hours
      Safety Issue?: No
  • Major Depression Inventory
    • Time Frame: 3-4 hours
      Safety Issue?: No
  • GAD-10 Anxiety Scale
    • Time Frame: 3-4 hours
      Safety Issue?: No
  • Health Survey SF-36
    • Time Frame: 3-4 hours
      Safety Issue?: No
  • McGill Pain Questionnaire
    • Time Frame: 3-4 hours
      Safety Issue?: No
  • Sweat test
    • Time Frame: 3-4 hours
      Safety Issue?: No
  • Heart rate variability testing
    • Time Frame: 3-4 hours
      Safety Issue?: No
  • Coping Strategy Questionnaire
    • Time Frame: 3-4 hours
      Safety Issue?: No
  • Pain Catastrophizing Scale
    • Time Frame: 3-4 hours
      Safety Issue?: No
  • Pain rating (VAS)
    • Time Frame: 3-4 hours
      Safety Issue?: No
  • Interview
    • Time Frame: 3-4 hours
      Safety Issue?: No

Criteria for Participation in this Clinical Trial

Inclusion Criteria:

  • Patients with panic disorder or depression

Exclusion Criteria:

  • Treatment with antidepressants, anticonvulsants or any other pain medication except paracetamol, SSRI and benzodiazepines
  • Serious or unstable medical disease
  • Prior or present diagnosis of mania, bipolar or psychotic disorder, delirium, suicidal, drug and alcohol dependence, severe agitation
  • Patients who cannot cooperate and do not understand Danish

Gender Eligibility for this Clinical Trial: Female

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: 75 Years

Are Healthy Volunteers Accepted for this Clinical Trial?: Accepts Healthy Volunteers

Clinical Trial Investigator Information

Lead Investigator: Danish Pain Research Center Other

Overall Clinical Trial Officials and Contacts

Lise Gormsen, MD Principal Investigator Danish Pain Research Center, Aarhus University Hospital  

Additional Information

Information obtained from ClinicalTrials.gov on February 12, 2012

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00560196

Study ID Number: PAD2007LG

ClinicalTrials.gov Identifier: NCT00560196

Health Authority: Denmark: Danish Dataprotection Agency

  • …
  • Tell a FriendPrint

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00560196